Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
University of Rochester
University of Rochester
The First Affiliated Hospital of Zhengzhou University
DEKA Biosciences
Second Xiangya Hospital of Central South University
Celldex Therapeutics
Biotech Pharmaceutical Co., Ltd.
University of Alabama at Birmingham
University of Chicago
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center